-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

Benzinga·10/19/2026 12:11:02
Chardan Capital analyst Andreas Argyrides initiates coverage on MannKind (NASDAQ:MNKD) with a Buy rating and announces Price Target of $10.